Viemed Healthcare(NASDAQ) VMD

Viemed helps people with chronic breathing issues stay at home. They provide medical machines and therapy to patients across America. This service helps patients avoid staying in the hospital.

The Medical Device Mix

• Ventilator Rentals: Devices used for non-invasive ventilation, which helps breathing without a tube, and invasive ventilation; accounted for 46.9% of revenue in Q1 2026.
• Sleep Therapy Gear: Positive Airway Pressure (PAP) machines and masks used to treat sleep apnea, a condition where breathing stops during sleep.
• Oxygen Therapy: Equipment and concentrators that provide extra oxygen to patients with Chronic Obstructive Pulmonary Disease (COPD), a chronic lung condition.
• Home Medical Equipment: Various tools and durable medical equipment (DME) like percussion vests used to clear patient lungs.
• Staffing Services: Solutions that provide qualified clinical professionals to external medical institutions and partners.

Expanding the Business Map

• Completed the acquisition of Lehan Drugs, Inc. on July 1, 2025, to add maternal health services and expand in the Midwest.
• Built a nationwide service network that now provides respiratory care to patients in all 50 states.
• Expanded the workforce of licensed respiratory therapists to 403 professionals as of March 31, 2026.

Why the Model Works

Viemed employs over 400 respiratory therapists who provide therapy and counseling to patients in their own homes. This clinical approach uses advanced technology to manage chronic diseases while reducing the need for expensive hospital stays.

Financial Growth in Q1 2026

• Revenue was $75.4 million in Q1 2026, up 27.5% from Q1 2025.
• Gross profit reached $42.8 million in Q1 2026, a 28.7% increase year-over-year.
• Operating income rose to $4.3 million in Q1 2026, up 11.8% from the prior year.
• Free cash flow hit $9.7 million for the fiscal year ended December 31, 2025.

Bottom Line

Viemed has transitioned from a local equipment provider into a nationwide clinical platform for respiratory care. Its evolution is driven by a focus on home-based treatment models and strategic acquisitions that expand its service offerings.